{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:03:10Z","timestamp":1791028990520,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1023\/a:1006463730337","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T02:03:28Z","timestamp":1040522608000},"page":"79-85","source":"Crossref","is-referenced-by-count":10,"title":["ATM heterozygosity and breast cancer: screening of 37 breast cancer patients for ATM mutations using a non-isotopic RNase cleavage-based assay"],"prefix":"10.1007","volume":"61","author":[{"given":"Karen C.","family":"Drumea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonine","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Shank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Mandell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Cropley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Obropta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Braccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Krupnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry S.","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"265424_CR1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000472285","volume":"3","author":"Y Shiloh","year":"1995","unstructured":"Shiloh Y: Ataxia telangiectasia: closer to unraveling the mystery. Eur J Hum Genet 3:116\u2013138, 1995","journal-title":"Eur J Hum Genet"},{"key":"265424_CR2","first-page":"89","volume":"77","author":"D Morell","year":"1986","unstructured":"Morell D, Cromartie E, Swift M: Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 77: 89\u201392, 1986","journal-title":"J Natl Cancer Inst"},{"key":"265424_CR3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/336577a0","volume":"336","author":"RA Gatti","year":"1988","unstructured":"Gatti RA, Berkel I, Boder E, Braedt C, Charmley P, Concannon P, Ersoy F, Foroud T, Jasper NGJ, Lange K, Lahtrop GM, Leppert M, Nakamura Y, O'Connell P, Paterson M, Salser W, Sanal O, Silver J, Sparkes RS, Susi E, Weeks DE, Wei S, White R, Yoder F: Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 336: 577\u2013580, 1988","journal-title":"Nature"},{"key":"265424_CR4","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","volume":"268","author":"K Savitsky","year":"1995","unstructured":"Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Seez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y: A single gene with a product similar to PI3-kinase and Rad 3 is mutated in ataxia telangiectasia. Science 268: 1749\u20131753, 1995","journal-title":"Science"},{"key":"265424_CR5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1086\/301673","volume":"62","author":"M Telatar","year":"1998","unstructured":"Telatar M, Teraoka S, Wang Z, Chun HH, Liang T, Castellvi-Bell S, Udar N, Borresen-Dale AL, Chessa L, Bernatowska-Matuzkievicz E, Porras O, Watanabe M, Junker A, Concannon P, Gatti R: Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. Am J Hum Genet 62: 86\u201397,1998","journal-title":"Am J Hum Genet"},{"key":"265424_CR6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O","volume":"10","author":"P Concannon","year":"1997","unstructured":"Concannon P, Gatti A: Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia. Hum Mutat 10: 100\u2013107, 1997","journal-title":"Hum Mutat"},{"key":"265424_CR7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpedi.1967.02090270073006","volume":"114","author":"SP Gotoff","year":"1967","unstructured":"Gotoff SP, Amirmokri E, Liebner EJ: Ataxia-telangiectasia. Am J Dis Child 114: 617\u2013625, 1967","journal-title":"Am J Dis Child"},{"key":"265424_CR8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/j.1460-2075.1994.tb06290.x","volume":"13","author":"R Dhand","year":"1994","unstructured":"Dhand R, Hues I, Panayotou G, Roche S, Fry MJ, Gout I, Totty NF, Truong O, Vicendo P, Yonezawa K, Kasuga M, Courtneidge SA, Waterfield MD: PI3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J 13: 522\u2013533, 1994","journal-title":"EMBO J"},{"key":"265424_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1042\/bj3040017","volume":"304","author":"JF Tanti","year":"1994","unstructured":"Tanti JF, Gremeaux T, Wan Obberghen F, LeMarchand-Brustel Y: Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. Biochem J 304: 17\u201321, 1994","journal-title":"Biochem J"},{"key":"265424_CR10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/bbrc.1995.1038","volume":"206","author":"GG Freund","year":"1995","unstructured":"Freund GG, Wittig JG, Mooney RA: The PI3-kinase serine kinase phosphorylates its p85 subunit and IRS-1 in PI3-kinase\/IRS1-complexes. Biochem Biophys Res Commun 206: 272\u2013278, 1995","journal-title":"Biochem Biophys Res Commun"},{"key":"265424_CR11","doi-asserted-by":"crossref","unstructured":"Harnden DG: The nature of ataxia-telangiectasia: problems and perspectives.Int J Radiat Biol 66: S13\u2013S19, 1994","DOI":"10.1080\/09553009414551811"},{"key":"265424_CR12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/09553009414550091","volume":"65","author":"AMR Taylor","year":"1994","unstructured":"Taylor AMR, Byrd PJ, McConville CM, Thacker S: Genetic and cellular features of ataxia-telangiectasia. Int J Radiat Biol 65: 65\u201370, 1994","journal-title":"Int J Radiat Biol"},{"key":"265424_CR13","first-page":"573","volume":"39","author":"M Swift","year":"1986","unstructured":"Swift M, Morell D, Cromartie E, Chamberlin AR, Skolnik MH, Bishop DT: The incidence and gene frequency of ataxiatelangiectasia in the United States.Am J Hum Genet 39: 573\u2013583, 1986","journal-title":"Am J Hum Genet"},{"key":"265424_CR14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/274484a0","volume":"274","author":"PC Chen","year":"1978","unstructured":"Chen PC, Lavin MF, Kidson C, Moss D: Identification of ataxia-telangiectasia heterozygotes, a cancer prone population. Nature 274: 484\u2013486, 1978","journal-title":"Nature"},{"key":"265424_CR15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2307\/3578071","volume":"128","author":"DE Weeks","year":"1991","unstructured":"Weeks DE, Paterson MC, Lange K, Andrais B, Davis RC, Yoder F, Gatti RA: Assessment of chronic radiosensitivity as an in vitro assay for heterozygote identification of ataxia-telangiectasia.Radiat Res 128: 90\u201399, 1991","journal-title":"Radiat Res"},{"key":"265424_CR16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/gcc.2870020412","volume":"2","author":"AL Borresen","year":"1990","unstructured":"Borresen AL, Anderson TI, Treti S, Heiberg A, Moller P: Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chrom Cancer 2: 339\u2013340, 1990","journal-title":"Genes Chrom Cancer"},{"key":"265424_CR17","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1056\/NEJM199112263252602","volume":"325","author":"M Swift","year":"1991","unstructured":"Swift M, Morrell D, Massey RB, Chase CL: Incidence of cancer in 161 families affected by ataxia-telangiectasia.N Engl J Med 325: 1831\u20131836, 1991","journal-title":"N Engl J Med"},{"key":"265424_CR18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0165-4608(96)00328-7","volume":"92","author":"P Athma","year":"1996","unstructured":"Athma P, Rappaport R, Swift M: Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92: 130\u2013134, 1996","journal-title":"Cancer Genet Cytogenet"},{"key":"265424_CR19","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM198705213162101","volume":"316","author":"M Swift","year":"1987","unstructured":"Swift M, Reitnauer PJ, Morel D, Chase CL: Breast and other cancers in families with ataxia-telangiectasia.N Engl J Med 316: 1289\u20131294, 1987","journal-title":"N Engl J Med"},{"key":"265424_CR20","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1080\/09553009414552011","volume":"66","author":"DF Easton","year":"1994","unstructured":"Easton DF: Cancer risk in ataxia-telangiectasia heterozygotes. lnt J Radiat Biol 66: S177\u2013S182, 1994","journal-title":"lnt J Radiat Biol"},{"key":"265424_CR21","first-page":"2929","volume":"48","author":"EC Pippard","year":"1988","unstructured":"Pippard EC, Hall AJ, Barker DJP, Bridges BA: Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain.Cancer Res 48: 2929\u20132932, 1988","journal-title":"Cancer Res"},{"key":"265424_CR22","first-page":"2726","volume":"56","author":"I Vorechovsky","year":"1996","unstructured":"Vorechovsky I, Rasio D, Luo L, Monaco C, Hammarstrom L, Webster ADB, Zaloudik J, Barbanti-Brodano G, James M, Russo G, Croce CM, Negrini M: The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res 56: 2726\u20132732, 1996","journal-title":"Cancer Res"},{"key":"265424_CR23","first-page":"1385","volume":"12","author":"JO Bay","year":"1998","unstructured":"Bay JO, Grancho M, Pernin D, Presneau N, Rio P, Tchirkov A, Uhrhammer N, Verrelle P, Gatti RA, Bignon YJ: No evidence for constitutional ATM mutation in breast\/gastric cancer families.Int J Oncol 12: 1385\u20131390, 1998","journal-title":"Int J Oncol"},{"key":"265424_CR24","first-page":"1376","volume":"58","author":"J Chen","year":"1998","unstructured":"Chen J, Giesler-Birkholtz G, Lindblom P, Rublo C and Lindblom A: The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res 58: 1376\u20131379, 1998","journal-title":"Cancer Res"},{"key":"265424_CR25","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/bjc.1997.593","volume":"76","author":"JM Appleby","year":"1997","unstructured":"Appleby JM, Barber JB, Levine E, Varley JM, Taylor AM, Stankovic T, Heighway J, Warren C, Scott D: Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy.Br J Cancer 76: 1546\u20131549, 1997","journal-title":"Br J Cancer"},{"key":"265424_CR26","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0360-3016(98)00171-0","volume":"41","author":"RA Clarke","year":"1998","unstructured":"Clarke RA, Goozee GR, Birrell G, Fang ZM, Hasnain H, LavinM, Kearsley JH: Absence of ATMtruncations in patients with severe acute radiation reactions. Int J Radiation Oncol Biol Phys 41: 1021\u20131027, 1998","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"265424_CR27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0167-8140(98)00014-0","volume":"47","author":"J Ramsay","year":"1998","unstructured":"Ramsay J, Birrell G, Lavin M: Testing for mutations of the ataxia-telangiectasia gene in radiosensitive breast cancer patients.Radiother Oncol 47: 125\u2013128, 1998","journal-title":"Radiother Oncol"},{"key":"265424_CR28","first-page":"106","volume":"21","author":"MM Goldrick","year":"1996","unstructured":"Goldrick MM, Kimball GR, Liu Q, Martin LA, Sommer SS, Tseng JY-H: NIRCA: A rapid robust method for screening for unknown point mutations. BioTechniques 21: 106\u2013112, 1996","journal-title":"BioTechniques"},{"key":"265424_CR29","first-page":"7.2.5-7.2.18","volume-title":"Current Protocols in Human Genetics","author":"HC Watkins","year":"1998","unstructured":"Watkins HC, M Goldrick: Cleavage of RNA\u2013RNA hybrids at mutation sites using the nonisotopic RNase cleavage assay (NIRCA).In: Dracopoli NC et al. (eds) Current Protocols in Human Genetics. Wiley, New York 1998, pp 7.2.5-7.2.18."},{"key":"265424_CR30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<156::AID-HUMU7>3.0.CO;2-E","volume":"14","author":"S Castellvi-Bel","year":"1999","unstructured":"Castellvi-Bel S, Sheikhavandi S, Telatar M, Tai L-Q, Hwang M, Wang Z, Yang Z, Cheng R, Gatti RA: New mutations, polymorphisms, and rare variants in the ATM gene detected by a novel SSCP strategy.Hum Mutat 14: 156\u2013162, 1999","journal-title":"Hum Mutat"},{"key":"265424_CR31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/mcpr.1998.0219","volume":"13","author":"P Maillet","year":"1999","unstructured":"Maillet P, Vaudan G, Chappuis P, Sappino A-P: PCR-mediated detection of a polymorphism in the ATM gene. Mol Cell Probes 13: 67\u201369, 1999","journal-title":"Mol Cell Probes"},{"key":"265424_CR32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/8.1.69","volume":"8","author":"N Sandoval","year":"1999","unstructured":"Sandoval N, Platzer M, Rosenthal A, Dork T, Bendix R, Skawran B, Stuhrmann M, Wegner R-D, Sperling K, Banin S, Shiloh Y, Baumer A, Bernthlaler U, Sennefelder H, Brohm M, Weber BHF, Schindler D: Characterization of ATMgene mutations in 66 ataxia-telangiectasia families.Hum Mol Genet 8: 69\u201379, 1999","journal-title":"Hum Mol Genet"},{"key":"265424_CR33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/ng1295-447","volume":"11","author":"AT De Souza","year":"1995","unstructured":"De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL: M6P\/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genet 11: 447\u2013449, 1995","journal-title":"Nature Genet"},{"key":"265424_CR34","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1086\/515472","volume":"60","author":"C Maslen","year":"1997","unstructured":"Maslen C, Babcock D, Raghunath M, Steinmann B: A rare branch-point mutation is associated with missplicing of fibrillin-Z in a large family with congenital contractural arachnodactyly.Am J Hum Genet 60: 1389\u20131398, 1997","journal-title":"Am J Hum Genet"},{"key":"265424_CR35","first-page":"1901","volume":"10","author":"T Tsai","year":"1996","unstructured":"Tsai T, Davalath S, Rankin C, Radich JP, Head D, Appelbaum FR, Boldt DH: Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies. Leukemia 10: 1901\u20131910, 1996","journal-title":"Leukemia"},{"key":"265424_CR36","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1073\/pnas.94.20.10895","volume":"94","author":"GS Firestein","year":"1997","unstructured":"Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR: Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium.Proc NatI Acad Sci USA 94: 10895\u201310900, 1997","journal-title":"Proc NatI Acad Sci USA"},{"key":"265424_CR37","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1086\/515467","volume":"60","author":"B Peral","year":"1997","unstructured":"Peral B, Gamble V, Strong C, Ong ACM, Sloane-Stanley J, Zerres K, Winearls CG, Harris PC: Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach. Am J Hum Genet 60: 1399\u2013 1410, 1997","journal-title":"Am J Hum Genet"},{"key":"265424_CR38","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1046\/j.1365-2141.1998.00914.x","volume":"102","author":"K Ritis","year":"1998","unstructured":"Ritis K, Steletas M, Tsiroxidoe V, Pardali E, Kanariol M, Moschese V, Orlandi P,SkordalaM, Rossi P, Kartalis G, Bourikas G, Sideras P: Absence of Bruton's tyrosine kinase (Btk) mutations in patients with acute myeloid leukaemia.Br J Haematol 102: 1241\u20131248, 1998","journal-title":"Br J Haematol"},{"key":"265424_CR39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/(SICI)1096-8628(19980113)75:2<141::AID-AJMG4>3.0.CO;2-W","volume":"75","author":"M Toyoshima","year":"1998","unstructured":"Toyoshima M, Hara T, Zhang H, Yamamoto T, Akaboshi S, Nanba E, Ohno K, Hori N, Sato K, Takeshita K: Ataxiatelangiectasia without immunodeficiency: novel point mutations within and adjacent to the phosphatidylinositol 3-kinaselike domain. Am J Med Genet 75: 141\u2013144, 1998","journal-title":"Am J Med Genet"},{"key":"265424_CR40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0165-4608(98)00109-5","volume":"108","author":"MJ Macera","year":"1999","unstructured":"Macera MJ, Godec CJ, Sharma N, Verma RS: Loss of heterozygosity of the TP53 tumor suppressor gene and detection of point mutations by the non-isotopic RNAse cleavage assay in prostate cancer.Cancer Genet Cytogenet 108: 42\u201347, 1999","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006463730337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006463730337\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1006463730337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006463730337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:32:22Z","timestamp":1750480342000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006463730337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["265424"],"URL":"https:\/\/doi.org\/10.1023\/a:1006463730337","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}